Cargando…

Immune and Inflammatory Processes in Obesity, Insulin Resistance, Diabetes, and Related Cardiometabolic Complications

Detalles Bibliográficos
Autores principales:	Ndisang, Joseph Fomusi, Rastogi, Sharad, Vannacci, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189852/ https://www.ncbi.nlm.nih.gov/pubmed/25328894 http://dx.doi.org/10.1155/2014/579560

Ejemplares similares

Oxidative Stress and Inflammation in Obesity, Diabetes, Hypertension, and Related Cardiometabolic Complications
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2014)

Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications 2015
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2015)

Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications 2017
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2017)

Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications: Current Status and Future Perspective
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2014)

Cardiometabolic Diseases and Related Complications: Current Status and Future Perspective
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2013)

Role of Heme Oxygenase in Inflammation, Insulin-Signalling, Diabetes and Obesity
por: Ndisang, Joseph Fomusi
Publicado: (2010)

The Risk of Heart Failure and Cardiometabolic Complications in Obesity May Be Masked by an Apparent Healthy Status of Normal Blood Glucose
por: Tiwari, Shuchita, et al.
Publicado: (2013)

Mechanisms by which heme oxygenase rescue renal dysfunction in obesity
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2014)

The Heme Oxygenase System Suppresses Perirenal Visceral Adiposity, Abates Renal Inflammation and Ameliorates Diabetic Nephropathy in Zucker Diabetic Fatty Rats
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2014)

The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes
por: Salley, Tatiana Ntube, et al.
Publicado: (2013)

Obesity, Insulin Resistance, and Asthma
por: Allinson, James P., et al.
Publicado: (2022)

Association of cardiometabolic risk factors with insulin resistance in overweight and obese children
por: Daneshzad, Elnaz, et al.
Publicado: (2022)

Contribution of insulin resistance to decreased baroreceptor sensitivity & cardiometabolic risks in pre-obesity & obesity
por: Indumathy, Jagadeeswaran, et al.
Publicado: (2018)

NO to Lysosomes: A Signal for Insulin Resistance in Obesity
por: Javaheri, Ali, et al.
Publicado: (2019)

Obesity in Children and Future Cardiometabolic Risk: Are blood tests necessary?
por: Logue, Jennifer, et al.
Publicado: (2010)

Immune, Inflammatory, and Oxidative Responses in Cardiovascular Complications
por: Ramana, Kota V., et al.
Publicado: (2016)

Prevention and Treatment of Cardiometabolic Diseases in Children with Overweight and Obesity: The Future of Healthcare
por: Calcaterra, Valeria, et al.
Publicado: (2022)

Inflammatory Biomarkers of Cardiometabolic Risk in Obese Egyptian Type 2 Diabetics
por: Barakat, Lamiaa A. A., et al.
Publicado: (2017)

Diet Quality, Cardiometabolic Risk and Diabetes
por: Della Pepa, Giuseppe
Publicado: (2023)

Mediators of insulin resistance & cardiometabolic risk: Newer insights
por: Bodhini, Dhanasekaran, et al.
Publicado: (2018)

Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome
por: Wittwer, Jennifer, et al.
Publicado: (2021)

A Potential New Treatment Option for Asthma in the Setting of Obesity or Insulin Resistance?
por: Forno, Erick
Publicado: (2021)

The Role of the Immune System in Obesity and Insulin Resistance
por: Patel, Payal S., et al.
Publicado: (2013)

Nutrients and Cardiometabolic Health in Type 2 Diabetes
por: Tricò, Domenico
Publicado: (2023)

Emerging Role of Aldosterone in Mediating the Vicious Cycle of Obesity, Insulin Resistance and Metabolic Syndrome
por: Park, Sungha
Publicado: (2018)

Implication of inflammatory signaling pathways in obesity-induced insulin resistance
por: Tanti, Jean-François, et al.
Publicado: (2013)

Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist
por: Crescioli, Giada, et al.
Publicado: (2022)

Inflammatory Mediators in Obesity
por: Kumar, Divya P., et al.
Publicado: (2019)

Obesity, Diabetes, and Cancer: The Role of the Insulin/IGF Axis; Mechanisms and Clinical Implications
por: Morrione, Andrea, et al.
Publicado: (2022)

Challenges in the treatment of cardiometabolic syndrome
por: Srivastava, Ambrish K.
Publicado: (2012)

CaMKII in Cardiometabolic Disease
por: Ozcan, Lale, et al.
Publicado: (2014)

Emergence of cardiometabolic risk in Bangladesh
por: Gupta, Rajeev
Publicado: (2016)

Hypertension and Cardiometabolic Risk Factors
por: Neves, Mario Fritsch, et al.
Publicado: (2013)

Oxidative Stress and Cardiometabolic Disorders
por: Akhigbe, Roland E., et al.
Publicado: (2021)

Antioxidant Foods and Cardiometabolic Health
por: Arribas, Silvia M., et al.
Publicado: (2022)

Insulin resistance versus insulin deficiency: evidence of racial differences in the pathogenesis of type 2 diabetes
por: Garg, Rajesh
Publicado: (2021)

Acanthosis nigricans as a composite marker of cardiometabolic risk and its complex association with obesity and insulin resistance in Mexican American children
por: Lopez-Alvarenga, Juan C., et al.
Publicado: (2020)

TG : HDL-C Ratio Is a Good Marker to Identify Children Affected by Obesity with Increased Cardiometabolic Risk and Insulin Resistance
por: Nur Zati Iwani, Ahmad Kamil, et al.
Publicado: (2019)

Avocado Consumption for 12 Weeks and Cardiometabolic Risk Factors: A Randomized Controlled Trial in Adults with Overweight or Obesity and Insulin Resistance
por: Zhang, Xuhuiqun, et al.
Publicado: (2022)

Biomarker-based Inflammatory Score in Obese Patients with Resistant Hypertension
por: Rodrigues, Cibele Isaac Saad
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cu3jk1qm9e5jlqj5qpogrkatul